Sangamo Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results and Recent Business Highlights

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. SPY
3. META
4. ABBV
5. FDX
6. IBM
7. MU
8. PFE
9. AWK
10. ACN

Go back to Sangamo Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results and Recent Business Highlights

Sangamo Therapeutics (SGMO) Tops Q4 EPS by 8c

February 24, 2022 4:55 PM EST

Sangamo Therapeutics (NASDAQ: SGMO) reported Q4 EPS of ($0.26), $0.08 better than the analyst estimate of ($0.34). Revenue for the quarter came in at $28 million versus the consensus estimate of $26.82 million.

For earnings history and earnings-related data on Sangamo Therapeutics (SGMO) click here.

... More